The rise of weight loss jabs isn't just transforming waistlines – it's set to reshape insurance risk.
As Will Marshall, Altea's Head of Legal and Risk Management emphasises in Insurance Post: "Patient selection is going to be an absolute key risk management issue." His insights highlight the critical need for properly informed consent, robust screening protocols and ongoing monitoring.
Click here to read the article.
